BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25398356)

  • 1. Methods in Enzymology. The use of CRISPR/Cas9, ZFNs, and TALENs in generating site-specific genome alterations. Preface.
    Doudna JA; Sontheimer EJ
    Methods Enzymol; 2014; 546():xix-xx. PubMed ID: 25398356
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome engineering using CRISPR-Cas9 system.
    Cong L; Zhang F
    Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant genome engineering in full bloom.
    Lozano-Juste J; Cutler SR
    Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
    Liang Z; Zhang K; Chen K; Gao C
    J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome editing: The domestication of Cas9.
    Urnov F
    Nature; 2016 Jan; 529(7587):468-9. PubMed ID: 26819037
    [No Abstract]   [Full Text] [Related]  

  • 7. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
    Jo YI; Suresh B; Kim H; Ramakrishna S
    Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
    Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
    J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics: Cleaving RNA with Cas9.
    Ghodsizadeh O
    Nat Methods; 2014 Nov; 11(11):1090. PubMed ID: 25551124
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR: gene editing is just the beginning.
    Ledford H
    Nature; 2016 Mar; 531(7593):156-9. PubMed ID: 26961639
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanding the Biologist's Toolkit with CRISPR-Cas9.
    Sternberg SH; Doudna JA
    Mol Cell; 2015 May; 58(4):568-74. PubMed ID: 26000842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic correction using engineered nucleases for gene therapy applications.
    Li HL; Nakano T; Hotta A
    Dev Growth Differ; 2014 Jan; 56(1):63-77. PubMed ID: 24329887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "CRISPR" validation of recessive brain cancer genes in vivo.
    Zuckermann M; Kawauchi D; Gronych J
    Oncotarget; 2015 Jul; 6(20):17865-6. PubMed ID: 26203775
    [No Abstract]   [Full Text] [Related]  

  • 17. Genome editing using Cas9 nickases.
    Trevino AE; Zhang F
    Methods Enzymol; 2014; 546():161-74. PubMed ID: 25398340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress of genome engineering technology via clustered regularly interspaced short palindromic repeats--a review].
    Li H; Qiu S; Song H
    Wei Sheng Wu Xue Bao; 2013 Oct; 53(10):1025-30. PubMed ID: 24409757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmable DNA cleavage in vitro by Cas9.
    Karvelis T; Gasiunas G; Siksnys V
    Biochem Soc Trans; 2013 Dec; 41(6):1401-6. PubMed ID: 24256227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of site-specific mutations in the rat genome via CRISPR/Cas9.
    Guan Y; Shao Y; Li D; Liu M
    Methods Enzymol; 2014; 546():297-317. PubMed ID: 25398346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.